在心室隔膜肌切除术期间同时进行冠状动脉旁路移植的临床结果
Tao Lu1, Changsheng Zhu1, Hao Cui2
1Department of Adult Cardiac Surgery Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College Beijing China.
Journal of the American Heart Association
|October 8, 2024
概括
在隔膜肌切除术期间同时进行冠状动脉旁路移植是安全有效的. 患者经历了优异的生存率和功能阶级的改善,与单独的隔膜肌切除术相比.
科学领域:
- 心血管外科心血管外科
- 心脏外科手术的结果
- 超性心肌病治疗方法 治疗方法
背景情况:
- 在隔膜切除术期间同时进行冠状动脉旁路移植 (CABG) 的临床特征和生存结果尚未得到充分确立.
- 截面肌切除术是一种用于治疗超阻塞性心肌病的外科手术.
- CABG是为了改善心脏肌肉的血流进行的.
研究的目的:
- 评估CABG与隔膜肌切除术同时进行的安全性和有效性.
- 分析并发性CABG的原因及其对患者存活率的影响.
- 为了比较结合手术结果与单独的隔膜肌切除术.
主要方法:
- 在2009年至2020年期间,对320名接受隔膜肌切除和CABG的患者进行了回顾性审查.
- 分析CABG (动脉样硬化冠状动脉疾病与心肌桥梁) 的原因.
- 术后结果的评估,包括左心室外流梯度,生存率和复合终点.
主要成果:
- 大多数CABG手术用于动脉样硬化冠状动脉疾病 (69.7%) 或心肌桥梁 (28.1%).
- 由于冠状动脉疾病而接受CABG的患者年龄较大,绕道时间较长,需要更多的移植 (P<0.05).
- 左心室外流梯度显著降低 (85.4至12.8毫米平,P<0.001),没有经过手术的死亡.
- 五年生存率很高 (>96%) 和一般肌肉切除队列 (P>0.05) 相当.
- 至少有一个动脉移植 (HR,0.47;P=0.034) 降低了发病率.
结论:
- 在隔膜肌切除术期间同时进行CABG是一种安全的程序.
- 患者获得了良好的术后结果,包括>95%的5年生存率和>90%的功能类改善.
- 结合手术的结果与单独的隔膜肌切除术相美.
相关概念视频
Cardiomyopathy VII: Pre and Post Operative Nursing Management
3
Patients with hypertrophic cardiomyopathy (HCM) and left ventricular outflow tract (LVOT) obstruction who remain symptomatic despite optimal medical therapy may undergo a septal myectomy (Morrow procedure). This procedure involves excising a portion of the hypertrophied septum below the aortic valve using a heart-lung machine to improve blood flow through the LVOT. Effective preoperative and postoperative nursing management ensures successful patient outcomes, minimizes complications, and...
3
Coronary Artery Disease V: Surgical Management
3
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
3
Cardiomyopathy V: Interprofessional Care
2
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
2
Cardiomyopathy III: Hypertrophic Cardiomyopathy
1
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
1
Mitral Stenosis I: Introduction
2
Mitral Valve Stenosis (MVS) is a heart condition where the mitral valve narrows, impeding blood circulation from the left atrium to the left ventricle. The etiology and pathophysiology of this condition are multifaceted, leading to a cascade of cardiovascular complications.Causes of Mitral Valve StenosisRheumatic Heart Disease: It is the main cause of mitral valve stenosis, particularly in developing nations. This condition arises from rheumatic fever, an inflammatory illness resulting from...
2
Coronary Artery Disease IV: Medical Management
11
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
11


